Effect of suramin on human esophageal cancer cells in vitro and in vivo

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 8, 1997, Pages 824-828

  Shin, R ^a   Naomoto, Y ^a   Kamikawa, Y ^a   Tanaka, N ^a   Orita, K ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Autophosphorylation; Epidermal growth factor receptor; Esophageal cancer; Suramin

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; SURAMIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0030834211     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529708996541     Document Type: Article

References (18)

1. Hawking F. Suramin: with special reference to onchocerciasis. Adv Pharm Chemother 1978;101:289.
2. Coffey R, Leof E, Shipley G. Suramin inhibition of growth factor recepter binding and mitogenicity in ARK-2 B cell. J Cell Phys 1987;132:143-8.
3. Danesi R, La Rocca RV, Stein CA, Neckers L, Myers CE. Effect of suramin on the human glioma cell line U706T. Proc AACR 1989;30:578.
4. Ewing MW, La Rocca RV, Stein CA, Myers CE, Linehan WM. Effect of suramin on proliferation of human prostate carcinoma. Proc AACR 1989;30:310.
5. Clark J, Chu M, Calabresi P. Growth inhibition of colon cancer cells by oenistein and suramin. Proc AACR 1989;30:557.
6. Fujiuchi S, Tsuji T, Ohsaki Y, Kikuchi K. The effect of suramin on human lung cancer cell line in vitro. Jpn J Cancer Chemother 1994;21:647-52.
7. Allan T, Van O. Suramin for prostatic cancer: a phase I/II study in advanced extensively pretreated disease. Eur J Cancer 1990; 26:422.
8. Yasui W, Yoshida K, Tahara E. Growth factors in human gastrointestinal carcinomas. Protein Nucl Acid Enzyme 1991; 36:1371-8.
9. Maeda Y, Hayashi Y, Koike M. Establishment of the nude mice xenograft and cell line (KEsC-1) of human esophageal carcinoma producing carcinoembryonic antigen. Igakunoayumi 1990;153:591-2.
10. Carmichel J, De Graff WG, Gazdar AF, Minna JD, Mitchell JB. Evaluation of tetrazolium-based semi-automated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47:936-41.
11. Heldin CH, Westermark B. Growth factors: mechanism of action and relation to oncogenes. Cell 1984;37:9-20.
12. Sporn MB, Todaro GJ. Autocrine and malignant transformation of cells. N Engl J Med 1980;303:878-80.
13. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 1991;64:271-80.
14. Olivier S, Formento P, Fischel L, Etienne MC, Milano G. Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur J Cancer 1990;26:867-71.
15. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Ann Rev Biochem 1988;57:443-78.
16. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203-12.
17. Massimo C, Oliver S, Keith CR. Suramin, an experimental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J Clin Invest 1992;89:1242-7.
18. Murayama Y. Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice. Ann Surg 1990;3:263-8.